[Retracted] miR‑143‑5p suppresses breast cancer progression by targeting the HIF‑1α‑related GLUT1 pathway
Jia Xu, Xi Li, Purong Zhang, Jie Luo, Exian Mou, Shiwei Liu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research · RNA modifications and cancer · Ferroptosis and cancer prognosis
Oncol Lett 23: 147, 2022; DOI: 10.3892/ol.2022.13268
Following the publication of this article, a concerned reader has drawn to the attention of the Editorial Office that certain of the colony-formation assay data shown in Fig. 6F on p. 9 had already been published in the following paper, written by different authors at different research institutes: Wu X, Cui F, Chen Y, Zhu Y and Liu F: Long non-coding RNA LOXL1-AS1 enhances colorectal cancer proliferation, migration and nvasion through miR-708-5p/CD44-EGFR axis. Onco Targets Ther 13: 7615–7627, 2020.
Owing to the fact that the contentious data in Fig. 6F of the above article had already been published prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.